NCT00319865View on ClinicalTrials.gov

PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma

PHASE2UnknownINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

September 30, 2008

Conditions

Multiple Myeloma

Interventions

DRUG

Velcade

DRUG

Thalidomide

DRUG

Adriamycin

DRUG

Dexamethasone

Trial Locations (1)

405-220

RECRUITING

Gachon University Gil Hospital, Inchon

Sponsors

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

Korean Multiple Myeloma Working Party

OTHER